<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">asurgery</journal-id><journal-title-group><journal-title xml:lang="ru">Амбулаторная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8741</issn><issn pub-type="epub">2782-2591</issn><publisher><publisher-name>ООО «ГРУППА РЕМЕДИУМ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/1995-1477-2021-18-2-32-36</article-id><article-id custom-type="elpub" pub-id-type="custom">asurgery-247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФЛЕБОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHLEBOLOGY</subject></subj-group></article-categories><title-group><article-title>Ранние результаты применения системы механохимической облитерации варикозных вен для лечения варикозной болезни</article-title><trans-title-group xml:lang="en"><trans-title>Early results of application of the system of mechanochemical obliteration of varicose veins for the treatment of varicose veins</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5990-8561</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кургинян</surname><given-names>Х. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurginyan</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кургинян Хачатур Михайлович, сосудистый хирург, флеболог, генеральный директор</p><p>119421, Москва, ул. Обручева, д. 21, лит. А</p></bio><bio xml:lang="en"><p>Khachatur M. Kurginyan, Vascular Surgeon, Phlebologist, Director General</p><p>21, Letter A, Obruchev St., Moscow, 119421</p></bio><email xlink:type="simple">bzhishk@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8295-9458</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Раскин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Raskin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Раскин Владимир Вячеславович, кандидат медицинских наук , сосудистый хирург, флеболог, врач УЗИ, ведущий сотрудник</p><p>115407, Москва, ул. Якорная, д. 7, корп. 1</p></bio><bio xml:lang="en"><p>Vladimir V. Raskin, Cand. Sci. (Med.), Vascular Surgeon, Phlebologist, Expert Sonographer, Lead Employer</p><p>7, Bldg. 1, Yakornaya St., Moscow, 115407</p></bio><email xlink:type="simple">vr25000@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4026-3863</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркин</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Markin</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркин Сергей Михайлович, кандидат медицинских наук , врач-хирург, руководитель центра флебологии</p><p>194017, Санкт-Петербург, проспект Тореза, д. 72, лит. А</p></bio><bio xml:lang="en"><p>Sergey M. Markin, Cand. Sci. (Med.), Surgeon, Head of the Phlebology Center</p><p>72, Letter A, Torez Ave., St Petersburg, 194017</p></bio><email xlink:type="simple">89052029192@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский центр «Медскан»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center “Medskan”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медицинский инновационный флебологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Innovative Phlebological Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Санкт-Петербургская клиническая больница Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St Petersburg Clinical Hospital of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>22</day><month>11</month><year>2021</year></pub-date><volume>18</volume><issue>2</issue><fpage>32</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кургинян Х.М., Раскин В.В., Маркин С.М., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Кургинян Х.М., Раскин В.В., Маркин С.М.</copyright-holder><copyright-holder xml:lang="en">Kurginyan K.V., Raskin V.V., Markin S.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.a-surgeon.ru/jour/article/view/247">https://www.a-surgeon.ru/jour/article/view/247</self-uri><abstract><sec><title>Введение</title><p>Введение. Поскольку основа варикозной болезни – это рефлюкс в магистральных подкожных венах, в настоящее время одним из основных принципов лечения варикозной болезни является именно устранение рефлюкса. «Золотым стандартом» является термооблитерация, однако нетермальные нетумесцентные методы также имеют ряд преимуществ. </p></sec><sec><title>Цель</title><p>Цель. Оценить безопасность и эффективность механохимической облитерации у пациентов с венозной недостаточностью при использовании катетера Flebogrif. </p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование вошли 8 женщин и 2 мужчины старше 18 лет с рефлюксом по БПВ при диаметре целевой вены не более 12 мм. Средний возраст пациентов составил 43,8 ± 11,5 лет. У 6 пациентов (60%) выявлена стадия С2 (варикозно-измененные подкожные вены), у 3 пациентов (30%) – стадия С3 (отек), у 1 пациента (10%) – стадия С4а (трофические изменения кожи и подкожных тканей, гиперпигментация и/или варикозная экзема). </p></sec><sec><title>Результаты</title><p>Результаты. После процедуры полная окклюзия целевых сегментов варикозной вены достигнута в 100 процентах случаев (10 пациентов) на всех исследуемых сроках (до 2 мес.). В проекции целевой вены пальпация оказалась безболезненной у всех пациентов. Также, по данным УЗИ, у всех пациентов на всех послеоперационных осмотрах наблюдалась полная окклюзия целевой вены, отсутствие полной или сегментарной реканализации. Нежелательных явлений и осложнений зарегистрировано не было. </p></sec><sec><title>Выводы</title><p>Выводы. Механохимическая облитерация является надежным способом устранения вертикального рефлюкса. Основные плюсы для пациента – быстрота, безболезненность, косметичность и амбулаторность процедуры. Большой плюс для врача, кроме скорости выполнения вмешательства и удовлетворенности пациента, – отсутствие необходимости в наличии сложных технических устройств (термогенераторов), а также отсутствие необходимости в тумесцентной анестезии, что делает процедуру более комфортной для больного. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The basis of varicose veins is reflux in the great saphenous veins, and at present one of the basic principles of treating varicose veins is to eliminate reflux. Thermal obliteration is the gold standard, but non-thermal non-tumescent methods have several advantages. </p></sec><sec><title>Target</title><p>Target. Evaluation of the safety and effectiveness of mechanochemical obliteration in patients with venous insufficiency using the Flebogrif catheter. </p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included 8 women and 2 men over 18 years of age with reflux along the GSV with a target vein diameter of no more than 12 mm. The average age of the patients was 43.8 ± 11.5 years. Stage C2 (varicose saphenous veins) was detected in six patients (60%), stage C3 (edema) in 3 patients (30%), stage C4a (trophic changes of skin and subcutaneous tissues, hyperpigmentation and/or varicose eczema) in one patient (10%). Results. After the procedure, complete occlusion of the target segments of the varicose vein was achieved in 100 percent of cases (10 patients) at all study periods (up to 2 months). Palpation in the projection of the target vein was painless in all patients. The ultrasound imaging showed complete occlusion of the target vein and the absence of complete or segmented recanalization in all patients during all postoperative examinations. No adverse events or complications were reported. </p></sec><sec><title>Conclusions</title><p>Conclusions. Mechanochemical obliteration is a reliable way to eliminate vertical reflux. The main advantages for the patient are speed, painlessness, beauty and outpatient procedures. A big plus for the doctor, in addition to the speed of the intervention and patient satisfaction, is the absence of the need for complex technical devices (thermogenerators), as well as the absence of the need for tumescent anesthesia, which makes the procedure more comfortable for the patient. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>варикоз</kwd><kwd>флебология</kwd><kwd>механохимия</kwd><kwd>хронические заболевания вен</kwd><kwd>хроническая венозная недостаточность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>varicose veins</kwd><kwd>phlebology</kwd><kwd>mechanochemistry</kwd><kwd>chronic venous diseases</kwd><kwd>chronic venous insufficiency</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Whiteley M.S., Dos Santos S.J., Lee C.T., J.-M.Li. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord. 2017;5(3):370–377. https://doi.org/10.1016/j.jvsv.2016.12.009.</mixed-citation><mixed-citation xml:lang="en">Whiteley M.S., Dos Santos S.J., Lee C.T., J.-M.Li. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord. 2017;5(3):370–377. https://doi.org/10.1016/j.jvsv.2016.12.009.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Boersma D., van Haelst S.T., van Eekeren R.R., Vink A., Reijnen M.M., de Vries J.P., de Borst G.J. Macroscopic and Histologic Analysis of Vessel Wall Reaction After Mechanochemical Endovenous Ablation Using the ClariVein OC Device in an Animal Model. Eur J Vasc Endovasc Surg. 2017;53(2):290–298. https://doi.org/10.1016/j.ejvs.2016.11.024.</mixed-citation><mixed-citation xml:lang="en">Boersma D., van Haelst S.T., van Eekeren R.R., Vink A., Reijnen M.M., de Vries J.P., de Borst G.J. Macroscopic and Histologic Analysis of Vessel Wall Reaction After Mechanochemical Endovenous Ablation Using the ClariVein OC Device in an Animal Model. Eur J Vasc Endovasc Surg. 2017;53(2):290–298. https://doi.org/10.1016/j.ejvs.2016.11.024.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ontario Health (Quality) . Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021;21(8):1–188. Available at: https://pubmed.ncbi.nlm.nih.gov/34211617.</mixed-citation><mixed-citation xml:lang="en">Ontario Health (Quality) . Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021;21(8):1–188. Available at: https://pubmed.ncbi.nlm.nih.gov/34211617.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alozai T., Huizing E., Schreve M., van Vlijmen C.J., Wisselink W., Ünlü Ç. A systematic review and meta-analysis of mechanochemical endovenous ablation using Flebogrif for varicose veins: A summary of evidence. J Vasc Surg Venous Lymphat Disord. 2021. https://doi.org/10.1016/j.jvsv.2021.05.010.</mixed-citation><mixed-citation xml:lang="en">Alozai T., Huizing E., Schreve M., van Vlijmen C.J., Wisselink W., Ünlü Ç. A systematic review and meta-analysis of mechanochemical endovenous ablation using Flebogrif for varicose veins: A summary of evidence. J Vasc Surg Venous Lymphat Disord. 2021. https://doi.org/10.1016/j.jvsv.2021.05.010.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ammollo R.P., Petrone A., Giribono A.M., Ferrante L., Del Guercio L, Bracale U.M. Early Results of Mechanochemical Ablation with Flebogrif in great Saphenous Vein Insufficiency: does Polidocanol Concentration Affect Outcome? Transl Med UniSa. 2020;21:47–51. Available at: https://pubmed.ncbi.nlm.nih.gov/32123682.</mixed-citation><mixed-citation xml:lang="en">Ammollo R.P., Petrone A., Giribono A.M., Ferrante L., Del Guercio L, Bracale U.M. Early Results of Mechanochemical Ablation with Flebogrif in great Saphenous Vein Insufficiency: does Polidocanol Concentration Affect Outcome? Transl Med UniSa. 2020;21:47–51. Available at: https://pubmed.ncbi.nlm.nih.gov/32123682.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zubilewicz T., Terlecki P., Terlecki K., Przywara S., Rybak J., Ilzecki M. Application of endovenous mechanochemical ablation (MOCA) with FlebogrifTM to treat varicose veins of the lower extremities: a single center experience over 3 months of observation. Acta Angiol. 2016;22(4):137–142. https://doi.org/10.5603/AA.2016.0012.</mixed-citation><mixed-citation xml:lang="en">Zubilewicz T., Terlecki P., Terlecki K., Przywara S., Rybak J., Ilzecki M. Application of endovenous mechanochemical ablation (MOCA) with FlebogrifTM to treat varicose veins of the lower extremities: a single center experience over 3 months of observation. Acta Angiol. 2016;22(4):137–142. https://doi.org/10.5603/AA.2016.0012.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tawfik A.M., Sorour W.A., El-Laboudy M.E. Laser ablation versus mechanochemical ablation in the treatment of primary varicose veins: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2020;8(2):211–215. https://doi.org/10.1016/j.jvsv.2019.10.025.</mixed-citation><mixed-citation xml:lang="en">Tawfik A.M., Sorour W.A., El-Laboudy M.E. Laser ablation versus mechanochemical ablation in the treatment of primary varicose veins: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2020;8(2):211–215. https://doi.org/10.1016/j.jvsv.2019.10.025.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
